These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 31856069

  • 1. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration.
    Scofield-Kaplan SM, Patel K, Jones FR, Hogan RN.
    J Neuroophthalmol; 2021 Mar 01; 41(1):e31-e33. PubMed ID: 31856069
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness.
    Starks V, Gilliland G, Vrcek I, Gilliland C.
    Orbit; 2016 Mar 01; 35(2):87-90. PubMed ID: 26928128
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension.
    Alsuhaibani AH, Carter KD, Nerad JA, Lee AG.
    Ophthalmology; 2011 Feb 01; 118(2):412-4. PubMed ID: 20801522
    [Abstract] [Full Text] [Related]

  • 7. Complications of Optic Nerve Sheath Fenestration as a Treatment for Idiopathic Intracranial Hypertension.
    Gilbert AL, Chwalisz B, Mallery R.
    Semin Ophthalmol; 2018 Feb 01; 33(1):36-41. PubMed ID: 29420144
    [Abstract] [Full Text] [Related]

  • 8. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions.
    Chandrasekaran S, McCluskey P, Minassian D, Assaad N.
    Clin Exp Ophthalmol; 2006 Feb 01; 34(7):661-5. PubMed ID: 16970759
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pediatric optic nerve sheath decompression.
    Thuente DD, Buckley EG.
    Ophthalmology; 2005 Apr 01; 112(4):724-7. PubMed ID: 15808268
    [Abstract] [Full Text] [Related]

  • 11. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration: Comment.
    Margolin E.
    J Neuroophthalmol; 2021 Mar 01; 41(1):135. PubMed ID: 32358434
    [No Abstract] [Full Text] [Related]

  • 12. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration: Response.
    Scofield-Kaplan SM, Patel KG, Jones FR, Hogan RN.
    J Neuroophthalmol; 2021 Mar 01; 41(1):135-136. PubMed ID: 32358437
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
    Wilkes BN, Siatkowski RM.
    J Neuroophthalmol; 2009 Dec 01; 29(4):281-3. PubMed ID: 19952899
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A 15-year review of secondary and tertiary optic nerve sheath fenestration for idiopathic intracranial hypertension.
    Anzeljc AJ, Frias P, Hayek BR, Canter Weiner N, Wojno TH, Kim HJ.
    Orbit; 2018 Aug 01; 37(4):266-272. PubMed ID: 29313398
    [Abstract] [Full Text] [Related]

  • 19. Optic nerve sheath fenestration: a revised lateral approach for nerve access.
    Blessing NW, Tse DT.
    Orbit; 2019 Apr 01; 38(2):137-143. PubMed ID: 29565728
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.